ENU induced mutations causing congenital cardiovascular anomalies

Development

Volumn 131, Issue 24, 2004, Pages 6211-6223

  Yu, Qing ^a   Shen, Yuan ^a   Chatterjee, Bishwanath ^a   Siegfried, Brett H ^a,b   Leatherbury, Linda ^a,c   Rosenthal, Julie ^a   Lucas, John F ^d   Wessels, Andy ^d   Spurney, Chris F ^a,c   Wu, Ying Jie ^a   Kirby, Margaret L ^e   Svenson, Karen ^f   Lo, Cecilia W ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f JACKSON LABORATORY   (United States)

Author keywords

Cardiovascular anomalies; Congenital heart defects; ENU mutagenesis; Mouse mutants; Ultrasound imaging

Indexed keywords

CONNEXIN 43; ETHYLNITROSOUREA; SEMAPHORIN; SEMAPHORIN 3C; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX1; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH INTERRUPTION; ARTICLE; CARDIOVASCULAR MALFORMATION; CHEMICAL MUTAGENESIS; CHROMOSOME 2; CHROMOSOME 4; CHROMOSOME MAP; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CRANIOFACIAL MALFORMATION; DIGEORGE SYNDROME; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FAMILY; FEMALE; FETUS; GENE MUTATION; GENETIC SCREENING; GREAT VESSELS TRANSPOSITION; HEART VENTRICLE SEPTUM DEFECT; HETEROZYGOTE; HIGH THROUGHPUT SCREENING; HOLT ORAM SYNDROME; HOMOZYGOTE; LIMB MALFORMATION; MALE; MICROSATELLITE MARKER; MOUSE; MUTATIONAL ANALYSIS; NON INVASIVE MEASUREMENT; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CHROMOSOMES, MAMMALIAN; CONNEXIN 43; DIGEORGE SYNDROME; ETHYLNITROSOUREA; FEMALE; FETUS; HEART DEFECTS, CONGENITAL; LIMB DEFORMITIES, CONGENITAL; MICE; MOLECULAR SEQUENCE DATA; MUTATION; T-BOX DOMAIN PROTEINS; TRUNCUS ARTERIOSUS, PERSISTENT;

ANIMALIA;

EID: 19944426358     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01543     Document Type: Article

References (66)

1. Ai, Z., Fischer, A., Spray, D. C., Brown, A. M. and Fishman, G. I. (2000). Wnt-1 regulation of connexin43 in cardiac myocytes. J. Clin. Invest. 105, 161-171.
2. Basson, C. T., Bachinsky, D. R., Lin, R. C., Levi, T., elkins, J. A., Soults, J., Grayzel, D., Kroumpouzou, E., Traill, T. A., Leblanc-Straceski, J. et al. (1997). Mutations in human Tbx5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 15, 30-35.
3. Brown, C. B., Feinter, L., Lu, M. M., Ma, X., Webber, A. L., Jia, L., Rapear, J. A. and Epstein, J. A. (2001). PlexinA2 and sempahorin signaling during cardiac neural crest development. Development 128, 3071-3080.
4. Bruneau, B. G., Nemer, G., Schmitt, J. P., Charron, F., Robitaille, L., Caron, S., Conner, D. A., Gessler, M., Nemer, M., Seidman, C. E. et al. (2001). A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 709-721.
5. Chilton, J. K. and Guthrie, S. (2003). Cranial expression of class 3 secreted semaphorins and their neuropilin receptors. Dev. Dyn. 228, 726-733.
6. Conti, E., Grifone, N., Sarkozy, A., Tandoi, C., Marino, B., Digilio, M. C., Mingarelli, R., Pizzuti, A. and Dallapiccola, B. (2003). DiGeorge subtypes of nonsyndronmic conotruncal defects: evidence againt a major role of TBX1 gene. Eur. J. Hum. Genetic 11, 349-351.
7. Costell, M., Gustafasson, E., Aszodi, A., Morgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R. and Fassler, R. (1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109-1122.
8. Costell, M., Carmona, R., Gustafsson, E., Gonzalez-Iriarte, M., Fassler, R. and Munoz-Chapuli, R. (2002). Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91, 158-164.
9. Cross, S. J., Ching, Y. H., Li, Q. Y., Armstrong-Buisseret, L., Spranger, S., Lyonnet, S., Bonnet, D., Penttinen, M., Jonveaux, P., Leheup, B. et al. (2000). The mutation spectrum in Holt-Oram syndrome. J. Med. Genet. 37, 785-787.
10. Eickholt, B. J., Mackenzie, S. L., Graham, A., Walsh, F. S. and Doherty, P. (1999). Evidence for collapsing-1 function in the control of neural crest migration in both trunk and hindbrain regions. Development 162, 2181-2189.
11. Favor, J. (1986). The frequency of dominant cataract and recessive specific-locus mutations in mice derived from 80 or 160 mg ethylnitrosourea per kg body weight treated spermtaogonia. Mutat. Res. 162, 69-80.
12. Feiner, L., Webber, A. L., Brown, C. B., Lu, M. M., Feinstein, P., Mombaerts, P., Epstein, J. A. and Raper, J. A. (2001). Targeted disruption of semaphoring 3C leads to persistent truncus arteriosus and aortic arch interruption. Development 128, 3061-3070.
13. Foote, C. I., Zhou, L., Zhu, X. and Nicholson, B. J. (1998). The pattern of disulfide linkages in the extracellular loop regions of connexin32 suggests a model for the docking interace of gap junctions. J. Cell Biol. 140, 1187-1197.
14. Gaio, U., Schweickert, A., Fischer, A., Garratt, A. N., Muller, T., Ozcelik, C., Lankes, W., Strehle, M., Britsch, S., Blum, M. et al. (1999). A role of the cryptic gene in the correct establishment of the left-right axis. Curr. Biol. 9, 1339-1342.
15. Garg, V., Kathiriya, I. S., Barnes, R., Schluterman, M. K., King, I. N., Butler, C. A., Rothrock, C. R., Eapen, R. S., Hirayama-Yamada, K., Joo, K. et al. (2003). GATA4 mutations cause human congenital heart defects and reveal an interaction with Tbx5. Nature 424, 443-447.
16. Gebbia, M., Ferrero, G. B., Pilia, G., Bassi, M. T., Aylsworth, A., Penman-Splitt, M., Bird, L. M., Bamforth, J. S., Burn, J., Schlessinger, D. et al. (1997). X-finked situs abnormalties result from mutations in ZIC3. Nat. Genet. 17, 305-308.
17. Giepmans, B. N., Hengeveld, T., Postma, F. R. and Moolenaar, W. H. (2001a). Interaction of c-Src with gap junction protein connexin-43. Role in the regulation of cell-cell communication. J. Biol. Chem. 276, 8544-8549.
18. Giepmans, B. N., Verlaan, I., Hengeveld, T., Janssen, H., Calafat, J., Falk, M. M. and Moolenaar, W. H. (2001b). Gap junction protein connexin-43 interacts directly with microtubules. Curr. Biol. 11, 1364-1368.
19. Gong, W., Gottlieb, S., Colins, J., Blescia, A., Dietz, H., Goldmuntz, E., McDonald-McGinn, D. M., Zackai, E. H., Emmanuel, B. S., Driscoll, A. et al. (2001). Mutation analysis of TBX1 in nondeleted patients with features of DGS/VCFS or isolated cardiovascular defects. J. Med. Genet. 38, E45.
20. Gui, Y.-H., Linask, K., Khowsathit, P. and Huhta, J. (1996). Doppler echocardiography of normal and abnormal embryonic mouse heart. Ped. Res. 40, 633-642.
21. Guris, D. L., Fantes, J., Tara, D., Druker, B. J. and Imamoto, A. (2001) Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat. Genet. 27, 293-298.
22. Hirawsawa, E. A., Watanabe, H., Takami, H., Hassell, J. R. and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nature 23, 354-358.
23. Hoffman, J. I. E. (1995). Incidence of congenital heart disease. II. Prenatal incidence. Pediatr. Cardiol. 16, 155-165.
24. Hoffman, J. I. E. and Kaplan, S. (2002). The incidence of congenital heart disease. Pediatr. Cardiol. 39, 1890-1900.
25. Huang, G. Y., Cooper, E. S., Waldo, K., Kirby, M. L., Gilula, N. B. and Lo, C. W. (1998a). Gap junction mediated cell-cell communication: modulates mouse neural crest migration. J. Cell Biol. 143, 1725-1734.
26. Huang, G., Wessels, A., Smith, B., Linask, K., Ewart, J. and Lo, C. (1998b). Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development. Dev. Biol. 198, 32-44.
27. Hutson, M. R. and Kirby, M. L. (2003). Neural crest and cardiovascular development: a 20 year perspective. Birth Defects Res. Part C. Embryo Today 69, 2-13.
28. Jerome, L. and Papaioannou, V. (2001). DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27, 286-240.
29. Jira, P. E., Waterham, H. R., Wanders, R. J. A., Smeitink, J. A. M., Sengers, R. C. A. and Wevers, R. A. (2003). Smith-Lemli-Opitz syndrome and the DHCR7 gene. Ann. Human Genet. 67, 269-280.
30. Kohlhase, J., Heinrich, M., Schubert, L., Liebers, M., Kispert, A., Laccone, F., Turnpenny, P., Winter, R. M. and Reardon, W. (2002). Okihiro syndrome is caused by SALL4 mutations. Hum. Mol. Genet. 23, 2979-2987.
31. Kolodkin, A. L., Matthes, D. I. and Goodman, C. S. (1993). The semaphoring genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75, 1389-1399.
32. Koppel, A. M. and Raper, J. A. (1998). Collapsin-1 covalently dimerizes, and dimerization is necessary for collapsing activity. J. Biol. Chem. 273, 15708-15713.
33. Koppel, A. M., Feiner, L., Kobayashi, H. and Raper, J. A. (1997). A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphoring family members. Neuron 19, 531-537.
34. Leatherbury, L., Yu, Q. and Lo, C. W. (2003). Noninvasive phenotypic analysis of cardiovascular structure and function in fetal mice using ultrasound. Birth Defects Res. Part C Embryo Today 69, 83-91.
35. Li, L., Krantz, I. D., Deng, Y., Genin, A., Banata, A. B., Collins, C. C., Qi, M., Trask, B. J., Kuo, W. L., Cochran, J. et al. (1997a). Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16, 243-251.
36. Li, Q. Y., Newbury-Ecob, R. A., Terrell, J. A., Wilson, D. I., Curtis, A. R., Yi, C. H., Gebuhr, T., Bullen, P. J., Robson, S. C., Strachan, T. et al. (1997b). Holt-Oram syndrome is caused by mutations in Tbx5, a member of the Brachyury (T) gene family. Nat. Genet. 15, 21-29.
37. Li, W. E. I, Waldo, K., Linask, K. L., Chen, T., Wessels, A., Parmacek, M. S., Kirby, M. L. and Lo, C. W. (2002). An essential role for connexin43 gap junctions in mouse coronary artery development. Development 129, 2031-2042.
38. Lichtner, P., Attie-Bitach, T., Schuffenhauer, S., Henwood, J., Bouvagnet, P., Scambler, P. J., Meitinger, T. and Vekemans, M. (2002). Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10P. J. Mol. Med. 81, 431-442.
39. Lindsay, E. A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparao, T., Jurecic, V., Ogunrinu, G., Sutherland, H. F., Scambler, P. J. et al. (2001). Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410 97-101.
40. Luo, Y., Raible, D. and Raper, J. A. (1993). Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75, 217-227.
41. Maki, J. M., Rasanen, J., Tikkanen, H., Sormunen, R., Makikallio, K. I, Kivirikko, K. I. and Soininen, R. (2002). Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106, 2503-2509.
42. Merscher, S., Funke, B., Epstein, J., Heyer, J., Puech, A., Lu, M., Xavier, R., Demay, M., Russell, R., Factor, S. et al. (2001). Tbx1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104, 619-629.
43. Monaco, G., Pignata, C., Rossi, E., Mascarello, O., Cocozza, S. and Ciccimarra, F. (1991). DiGeorge anomaly associated with 10p deletion. Am. J. Med Genet. 39, 215-216.
44. Mori, A. D. and Bruneau, B. G. (2004). Tbx5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr. Opin. Cardiol. 19, 211-215.
45. Neuhaus, I. and Beier, D. (1998). Efficient localization of mutations by interval haplotype analysis. Mamm. Genome 9, 150-154.
46. Oda, T., Elkahloun, A. G., Pike, B. L., Okajima, K., Krantz, I. D., Genin, A., Piccoli, D. A., Meltzer, P. S., Spinner, N. B., Collins, F. S. et al. (1997). Mutations in the human Jagged 1 gene are responsible for Alagille syndrome. Nat. Genet. 16, 235-242.
47. Oh, S. P. and Li, E. (1997). The signaling pathway mediated by the type IIB activin receptor contorlws axial patterning and lateral asymmetry in the mouse. Genes Dev. 11, 1812-1826.
48. Pickard, G., Sollars, P., Rinchik, E., Nolan, P. and Bucan, M. (1995). Mutagenesis and behaviorial screening for altered circadian activity identifies the mouse mutant, Wheels. Brain Res. 705, 255-266.
49. Reaume, A. G., de Sousa, P. A., Kulkarni, S., Langille, B. L., Zhu, D., Davies, T. C., Juneja, S. C., Kidder, G. M. and Rossant, J. (1995). Cardiac malformation in neonatal mice lacking connexin43. Science 267, 1831-1834.
50. Rosenthal, G. (1998). Prevalence of congenital heart disease. In The Science and Practice of Pediatric Cardiology, 2nd Edition, pp. 1083-1105. Baltimore, MD: Lippincott Williams & Wilkins.
51. Satoda, M., Zhao, F., Diaz, G. A., Burn, J., Goodship, J., Davidson, H. R., Pierpont, M. E. M. and Gelb, B. D. (2000). Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat. Genet. 25, 42-46.
52. Schott, J. J., Benson, D. W., Basson, C. T., Pease, W., Silberbach, G. M., Moak, J. P., Maron, B. J., Seidman, C. E. and Seidman, J. G. (1998). Congenital heart disease caused by mutations in the transcription factor NKX2.5. Science 281, 108-111.
53. Schuffenhauer, S., Lichtner, P., Peykar-Derakhshandeh, P., Marken, J., Haas, O. A., Back, E., Wolff, G., Zabel, B., Barisic, I, Rauch, A. et al. (1998). Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2). Eur J. Hum. Genet. 6, 213-225.
54. Srinivaswan, S., Scott, B. H., Aristizabal, O., Lia, K., Labow, M., Artman, M. and Turnbull, D. (1998). Noninvasive in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation 98, 912-918.
55. Strauss, A. (1998). The molecular basis of congenital cardiac disease. Semin. Thoracic Cardiovasc. Surg. 1, 179-188.
56. Svenson, K., Bogue, M. and Peters, L. (2003). Identifying new mouse models of cardiovascular disease: a review of high throughput screens of mutagenized and inbred strains. J. Appl. Physiol. 94, 1650-1659.
57. Tamagnone, L. and Comoglio, P. M. (2004). To move or not to move? EMBO Rep. 5, 356-361.
58. Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S. et al. (2001). Mutations in PTPN11 encoding for protein tyhrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465-468.
59. Toyofuku, T., Yabuki, M., Otsu, K., Kuzuya, T., Hori, M. and Tada, M. (1998). Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J. Biol. Chem. 273 12725-12731.
60. Van Esch, H., Groenen, P., Fryns, J., van de Ven, W. and Devriendt, K. (1999). The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome. Genet. Couns. 10, 59-65.
61. Vitaterna, M., King, D.-P., Chang, A., Kornhauser, J., Lowrey, P., McDonald, J., Dove, W., Pinto, L., Truek, F. and Takahashi, J. (1994). Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 264, 719-725.
62. Weber, J., Salinger, A. and Justice, M. (2000). Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strains. Genesis 26, 230-233.
63. Weninger, W. J. and Mohun, T. (2002). Phenotyping transgenic embryos: a rapid 3-D screening method based on episcopic fluorescence image capturing. Nat. Genet. 30, 59-65.
64. Yagi, H., Furutani, Y., Hamada, H., Sasaki, T., Asakawa, S., Mionoshima, S., Ichida, F., Joo, K., Kimura, M., Imamura, S. et al. (2003). Role of Tbx1 in human del22q11.2 syndrome. Lancet 362 1366-1373.
65. Yamagishi, C., Heirck, B., Gittenberger-de Groot, A., Yamagishi, H. and Srivastava, D. (2003). Functional attenuation of UFD11, a 22q11.2 deletion syndrome candidate gene, leads to cardiac outflow septation defects in chicken embryos. Pediatr. Res. 53 546-553
66. Zhou, Y., Foster, F., Qu, D., Zhang, M., Harasiewicz, K. and Adamson, S. (2002). Applications for multifrequency ultrasound biomicroscopy in mice from implantation to adulthood. Physiol. Genomics 10, 1-14.